William W. Phillips

Massachusetts General Hospital

Papers

1

Total Citations

7

H-Index

1

About

William W. Phillips is a pioneering thoracic surgeon and translational researcher whose work centers on precision oncology, drug delivery systems, and intraoperative diagnostics for lung cancer. His most notable contribution is leading the first-in-human intrathoracic implantation of multidrug-eluting microdevices for in situ chemotherapeutic sensitivity testing in nonsmall cell lung cancer (NSCLC). This landmark 2022 study, cited 7 times, demonstrated the safety and feasibility of implanting and retrieving these novel microdevices during operative resection—a proof-of-concept that could revolutionize personalized adjuvant therapy by predicting optimal treatments directly from the tumor microenvironment. Phillips’s research bridges surgical innovation and molecular pharmacology, aiming to overcome the longstanding challenge of ineffective postsurgical outcomes in NSCLC. His work has been recognized for its translational impact, offering a pathway to tailor chemotherapy regimens in real time. As a leader in thoracic oncology, Phillips continues to advance implantable technologies that promise to transform how clinicians assess drug sensitivity, reduce unnecessary toxicity, and improve survival for lung cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
First-in-Human Intrathoracic Implantation of Multidrug-Eluting Microdevices for In Situ Chemotherapeutic Sensitivity Testing as Proof of Concept in Nonsmall Cell Lung Cancer
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Massachusetts General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago